The HT is a gamble - do you go for it now which halves the recurrence rate in high risk cancer, or do you duck out of it now and increase the risk of having to go on it lifelong later?
Having said that, the most important part of it is before RT, concurrent with RT, and after RT. The further out you go after the RT, you are probably gaining proportionally less. However, the case where it probably is most important is where you have a high risk cancer with micromets because you are probably relying on the HT to kill the micromets after the main tumour has been killed (in so far as we understand how it works, which is rather limited). It sounds like they think this could be your case with possibly lymph node involvement. In the UK, in the case of lymph node involvement, you might have got chemo or one of the more advanced hormone therapy drugs in addition to Eligard (which is same drug as Prostap here, except Prostap doesn't come in 6 monthly doses).
Did your RT also target pelvic lymph nodes?
Edited by member 18 Dec 2023 at 09:24
| Reason: Not specified